NGM Biopharmaceuticals Inc (0IK.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 08:06AM CEST
| Previous close | 1.4000 |
| Open | 1.4000 |
| Bid | 1.4000 x 0 |
| Ask | 1.4700 x 0 |
| Day's range | 1.4000 - 1.4000 |
| 52-week range | 0.5400 - 4.0000 |
| Volume | |
| Avg. volume | 57 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates
NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 10.81% and 91.75%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Why NGM Biopharmaceuticals (NGM) Might Surprise This Earnings Season
NGM Biopharmaceuticals (NGM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Simply Wall St.
Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75% over the previous year
Key Insights Given the large stake in the stock by institutions, NGM Biopharmaceuticals' stock price might be...
© 2024 Yahoo. All rights reserved.